sodium iodide i-131 37 - 7400 mbq kapseli terapiaan
curium netherlands b.v. - 131i-sodiumiodide - kapseli terapiaan - 37 - 7400 mbq - natriumjodidi(131i)
sodium iodide i-123 37 mbq/ml injektioneste
curium netherlands b.v. - 123i-sodiumiodide - injektioneste - 37 mbq/ml - natriumjodidi(123i)
pedmarqsi
fennec pharmaceuticals (eu) limited - sodium thiosulfate - ear diseases; ototoxicity - kaikki muut terapeuttiset tuotteet - pedmarqsi is indicated for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to < 18 years of age with localised, non-metastatic, solid tumours.
picorion 7.5 mg/ml tipat, liuos
orion corporation - sodium picosulfate - tipat, liuos - 7.5 mg/ml - natriumpikosulfaatti
laxoberon 7.5 mg/ml tipat, liuos
opella healthcare france sas - sodium picosulfate monohydrate - tipat, liuos - 7.5 mg/ml - natriumpikosulfaatti
laxoberon 2.5 mg kapseli, pehmeä
opella healthcare france sas - sodium picosulfate monohydrate - kapseli, pehmeä - 2.5 mg - natriumpikosulfaatti
picorion 5 mg tabletti
orion corporation - sodium picosulfate monohydrate - tabletti - 5 mg - natriumpikosulfaatti
sodium iodide i-131 0.6 - 3.7 mbq kapseli diagnostiikkaan
mallinckrodt medical b.v. - natrii iodidum (131i) - kapseli diagnostiikkaan - 0.6 - 3.7 mbq - natriumjodidi(131i)
triumeq
viiv healthcare b.v. - dolutegravir sodium, lamivudine, abacavir (as sulfate) - hiv-infektiot - antiviraalit systeemiseen käyttöön - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children weighing at least 25 kg who are antiretroviral treatment-naïve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents in triumeq.
theracap 37 mbq - 5.55 gbq kapseli, kova
ge healthcare buchler gmbh & co.kg - 131i-sodiumiodide - kapseli, kova - 37 mbq - 5.55 gbq - natriumjodidi(131i)